1. Ibuprofen Treatment for Closure of Patent Ductus Arteriosus Is Not Associated With Increased Risk of Neuropathology
- Author
-
Donald C. McCurnin, Michelle Loeliger, Bradley A. Yoder, Amy Shields, Terrie E. Inder, Ronald I. Clyman, and Sandra Rees
- Subjects
Time Factors ,Gestational Age ,Ibuprofen ,Neuropathology ,Article ,Positive-Pressure Respiration ,biology.animal ,Ductus arteriosus ,Glial Fibrillary Acidic Protein ,medicine ,Animals ,Cyclooxygenase Inhibitors ,Ductus Arteriosus, Patent ,Fetus ,biology ,Glial fibrillary acidic protein ,business.industry ,Macrophages ,organic chemicals ,Brain ,Pulmonary Surfactants ,medicine.disease ,Disease Models, Animal ,medicine.anatomical_structure ,Animals, Newborn ,Premature birth ,Astrocytes ,Anesthesia ,embryonic structures ,Pediatrics, Perinatology and Child Health ,biology.protein ,Premature Birth ,Gestation ,Microglia ,business ,Papio ,Baboon ,medicine.drug - Abstract
Ibuprofen is an effective pharmacological intervention for closure of a patent ductus arteriosus in preterm infants, and is an alternative to surgical ligation; however it is not certain whether ibuprofen treatment is associated with adverse effects on the brain. Therefore, this study examined neuropathological outcomes of ibuprofen therapy for a patent ductus arteriosus. Fetal baboons were delivered at 125-days of gestation (dg, term ~185dg) by caesarean section, given surfactant and ventilated for 14-days with positive pressure ventilation. Baboons were randomly allocated to receive either ibuprofen (PPV + ibuprofen, n=8) or no therapy (PPV, n=5). Animals were euthanased on day 14 and brains assessed for cerebral growth, development and neuropathology. Body and brain weights, the total volume of the brain and the surface folding index (measure of brain growth) were not different (p>0.05) between PPV + ibuprofen-treated and PPV animals. There was no difference (p>0.05) in the number of myelin basic protein-immunoreactive oligodendrocytes, glial fibrillary acid protein-immunoreactive astrocytes or Iba1-immunoreactive macrophages/microglia in the forebrain. No overt cerebellar alterations were observed in either group. Ibuprofen treatment for patent ductus arteriosus closure in the preterm baboon neonate is not associated with any increased risk of neuropathology or alterations to brain growth and development.
- Published
- 2010